Tamoxifen induced apoptosis in ZR-75 breast cancer xenografts antedates tumour regression

Breast Cancer Research and Treatment

Volumn 45, Issue 2, 1997, Pages 99-107

  Cameron, D A ^a   Ritchie, A A ^a   Langdon, S ^a   Anderson, T J ^b   Miller, W R ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Apoptosis; MDA MB 231; Mitosis; Necrosis; Regression; Tamoxifen; ZR 75 1

Indexed keywords

ANTIESTROGEN; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MITOSIS; MOUSE; NONHUMAN; NUDE MOUSE; PREDICTION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME; TUMOR REGRESSION; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; BREAST NEOPLASMS; CELL DIVISION; FEMALE; MICE; MICE, NUDE; MITOTIC INDEX; NEOPLASM TRANSPLANTATION; TAMOXIFEN; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0030874542     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005850827825     Document Type: Article

References (26)

1. Wolf DM, Fuqua SAW: Mechanisms of action of antiestrogens. Cancer Treat Rev 21: 247-271, 1995
2. Allan SG, Rodger A, Smyth JF, Leonard RCF, Chetty U, Forrest APM: Tamoxifen as primary treatment of breast cancer in elderly or frail patients: a practical management. Br Med J 290: 358-358, 1985
3. Gazet J-C, Ford HT, Coombes RC, Bland JM, Sutcliffe R, Quilliam J, Lowndes S: Prospective randomized trial of tamoxifen vs surgery in elderly patients with breast cancer. Eur J Surg Oncol 20: 207-214, 1994
4. Gaskell DJ, Hawkins RA, de Carteret S, Chetty U, Sangster K, Forrest APM: Indications for primary tamoxifen therapy in elderly women with breast cancer. Br J Surg 79: 1317-1320, 1992
5. Schwartzman RA, Cidlowski JA: Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocrine Rev 14: 133-151, 1993
6. Osborne CK, Boldt CH, Clark GM, Trent JM: Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase. Cancer Res 43: 3583-3585, 1983
7. Brunner N, Bronzert D, Vindeløv LL, Rygaard K, Spang-Thomsen M, Lippman ME: Effect on growth and cell cycle kinetics of estradiol and tamoxifen on MCF-7 human breast cancer cells grown in vitro and in nude mice. Cancer Res 49: 1515-1520, 1989
8. Kyprianou N, English HF, Davidson NE, Isaacs JT: Programmed cell death during regression of MCF-7 human breast cancer following estrogen ablation. Cancer Res 51: 162-166, 1991
9. Warri AM, Huovinen RL, Martikainen PM, Härkönen PL: Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro. J Natl Cancer Inst 85: 1412-1418, 1993
10. Brugal G, Dye R, Krief B, Chassery J-M, Tanke H, Tucker JH: HOME: Highly Optimized Microscope Environment. Cytometry 13: 109-116, 1992
11. Cohen JJ: Apoptosis. Immunol Today 14: 126-130, 1993
12. van Diest PJ, Baak JPA, Matze-Cok P, Wisse-Brekelmans ECM, van Galen CM, Kurver PHJ, Bellot SM, Fijnheer J, van Gorp LHM, Kwee WS, Los J, Peterse JL, Ruitenberg HM, Schapers RFM, Schipper MEI, Somsen JG, Willig WPM, Ariens ATh: Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the multicenter morphometric mammary carcinoma project. Hum Pathol 23: 603-607, 1992
13. Arends MJ, McGregor AH, Wyllie AH: Apoptosis is inversely related to necrosis and determines net growth in tumors bearing constitutively expressed myc, ras and HPV oncogenes. Am J Pathol 144: 1045-1057, 1994
14. Bland JM, Altman DG: Measurement error. Br Med J 313: 744-744, 1996
15. Steel CG: Growth kinetics of tumours. Clarendon Press, Oxford. 1977, p 21.
16. Tominaga T, Yoshida Y, Matsumoto A, Hayashi K, Kosaki G: Effects of tamoxifen and the derivative (tat) on cell-cycle of MCF-7 in vitro. Anticancer Res 13: 661-666, 1993
17. Sarkaria JN, Gibson DFC, Jordan VC, Fowler JF, Lindstrom MJ, Mulcahy RT: Tamoxifen-induced increase in the potential doubling time of MCF-7 xenografts as determined by bromodeoxyuridine labelling and flow cytometry. Cancer Res 530: 4413-4417, 1993
18. Wang TTY, Phang JM: Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7. Cancer Res 55: 2487-2489, 1995
19. 31P magnetic resonance spectroscopy, creatine kinase activity and apoptotic index. Cancer Res 55: 4146-4150, 1995
20. Kerr JFR, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239-257, 1972
21. Wijsman JH, Cornelisse CJ, Keijzer R, van de Velde CJH, Elvers B, van Dierendonck JH: Effect of hormone depletion on cell survival in the EMR-86 rat mamary carcinoma. Br J Cancer 73: 1210-1215, 1996
22. Gold R, Schmeid M, Giegerich G, Breischopf H, Hartung HP, Toyka KV: Differentialion between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest 71: 219-225, 1994
23. Gagliardi A, Collins DC: Inhibition of angiogenesis by antioestrogens. Cancer Res 530: 533-535, 1993
24. Haran EF, Maretzek AF, Goldberg I, Degani H: Tamoxifen enhances cell death in implanted MCF7 breast cancer by inhibiting endothelium growth. Cancer Res 549: 5511-5514, 1994
25. Dowsett M, Johnston SRD, Newby J, Golding M, Sacks N, Smith IE: Mechanisms of hormone response: a role for apoptosis. Endocrine-Related Cancer 2: 3-11, 1995
26. Gorczyca W, Tuziak T, Kram A, Melamed MR, Darzynkiewicz Z: Detection of apoptosis-associated DNA strand breaks in fine-needle aspiration biopsies by in situ end labelling of fragmented DNA. Cytometry 15: 169-175, 1994